Amoy Diagnostics Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date of 23 May 2023
May 16, 2023 at 03:33 pm EDT
Share
Amoy Diagnostics Co., Ltd. announced 2022 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 1.40000000. Record date: 22 May 2023, Ex-date: 23 May 2023 and Payment date: 23 May 2023. 10% withholding tax on cash dividend will be deducted in CNY within the cash dividend receivable.
Please refer to below details: Tax on cash dividend/10 shares: CNY0.14000000(10% x CNY1.40000000) Net cash dividend/10 shares after tax: CNY1.26000000(CNY1.40000000- CNY0.14000000).
Amoy Diagnostics Co Ltd is a pharmaceutical company engaged in research, development, production and sales of molecular diagnostic products. The Company provides testing reagents and testing services for tumor diagnosis. The Companyâs testing reagent products include ADx-ARMS product line for tumor tissue specimen detection, Super-ARMS product line for liquid biopsy, the NGS product line and the FISH product line. The products are used for the detection of non-small cell lung cancer, colorectal cancer, thyroid cancer, melanoma and other malignant tumors. The Company also provides data software to capture and analyze gene sequencing data. The Company provides testing services through its own medical testing institutions, including lung cancer testing, colorectal cancer testing and breast cancer testing.
AMOY DIAGNOSTICS CO., LTD. 
